Provided by Tiger Fintech (Singapore) Pte. Ltd.

Citius Pharmaceuticals, Inc.

1.08
+0.167418.34%
Post-market: 1.130.0500+4.63%19:59 EDT
Volume:2.91M
Turnover:3.19M
Market Cap:12.07M
PE:-0.19
High:1.24
Open:0.9380
Low:0.8822
Close:0.9126
Loading ...

Citius Pharmaceuticals Inc : Maxim Group Cuts to Hold From Buy

THOMSON REUTERS
·
23 May

Citius Pharmaceuticals downgraded to Hold from Buy at Maxim

TIPRANKS
·
23 May

Citius Pharmaceuticals Is Maintained at Buy by D. Boral Capital

Dow Jones
·
16 May

Citius Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

Citius Pharma Q2 EPS $(1.27) Misses $0.33 Estimate

Benzinga
·
15 May

Citius Pharmaceuticals Reports Q2 2025 Financials: Net Loss Widens to $11.5 Million, EPS at ($1.27)

Reuters
·
15 May

Citius Pharmaceuticals Q2 Basic EPS USD -1.27

THOMSON REUTERS
·
15 May

Citius Pharmaceuticals Inc: Will Need to Secure Additional Capital to Support Operations Beyond May 2025

THOMSON REUTERS
·
15 May

Press Release: Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update

Dow Jones
·
15 May

Citius Pharmaceuticals Inc expected to post earnings of 33 cents a share - Earnings Preview

Reuters
·
09 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
08 May

Citius Pharmaceuticals target adjusted to $4 for split at H.C. Wainwright

TIPRANKS
·
11 Apr

Citius Pharmaceuticals Announces $2 Million Registered Direct Offering of Common Stock

THOMSON REUTERS
·
01 Apr

Citius Pharmaceuticals Announces $2 Million Registered Direct Offering of Common Stock

PR Newswire
·
01 Apr

Citius Pharmaceuticals Is Maintained at Buy by D. Boral Capital

Dow Jones
·
18 Feb

Citius Pharmaceuticals Inc: Q1 Net Loss $1.30 per Share

THOMSON REUTERS
·
15 Feb

Citius Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
15 Feb

Citius Pharmaceuticals Inc expected to post a loss of 58 cents a share - Earnings Preview

Reuters
·
10 Feb

Citius Pharmaceuticals and Citius Oncology announce J-Code issued for Lymphir

TIPRANKS
·
06 Feb

Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for Lymphir by Centers for Medicare and Medicaid Services

THOMSON REUTERS
·
06 Feb